Related Content
Download content relating to this event and topic.
The region’s premier knowledge-sharing platform, featuring success stories from Asian biopharmas and expert insights from global biomanufacturing leaders on the latest innovations, process optimization, and regulatory advancements.

The 13th Annual Biologics Manufacturing Asia 2026 is Asia’s premier bioprocessing-focused conference, providing a dedicated platform for regional biopharmaceutical industry stakeholders to network, explore strategic collaborations, and gain insights into the latest manufacturing technologies and advancements.
This year’s agenda is designed to highlight success stories from Asia’s leading biopharma companies while incorporating technical expertise from global biopharma leaders, top pharmaceutical companies, and regulators. Key topics will include cutting-edge manufacturing technologies such as single-use systems and end-to-end continuous processing, challenges and opportunities in biomanufacturing, advancements in upstream process development, cost optimization and timeline reduction in downstream processing, analytical characterization strategies, facility design and scale-up, emerging biologics manufacturing technologies, regulatory updates, and novel biologics modalities.
Building on the tremendous success of the 12th Annual Biologics Manufacturing Asia 2025, we are committed to delivering the most comprehensive and impactful knowledge-sharing platform at the 13th Annual Biologics Manufacturing Asia 2026.


View the Key Themes for
Biologics Manufacturing Asia 2026
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.


Dr. Gang Qin, Ph.D. (University of Göttingen), is the Founder and CEO of GeneQuantum Healthcare. With over 20 years of international experience in biopharmaceutical R&D and leadership—spanning roles at the Max Planck Institute and the Chinese Academy of Sciences—Dr. Qin is a recognized innovator in the field, credited with numerous high-impact scientific publications and over 180 patent applications as a core inventor.
At GeneQuantum, Dr. Qin leads the company’s mission to revolutionize targeted cancer therapies through its proprietary, enzyme-mediated site-specific conjugation technologies. Under his leadership, GeneQuantum has established a fully integrated, high-throughput platform for the discovery and manufacturing of next-generation XDC therapeutics. This end-to-end solution supports the efficient development of best-in-class and first-in-class (BIC/FIC) XDC candidates, targeting oncology and other indications with substantial unmet medical needs and high market potential.


Heonchang Lim is the Director of Formulation Development at Samsung Biologics’ CDO division, where he leads a team dedicated to developing innovative drug formulations. With over 15 years of experience in the biopharmaceutical industry, Heonchang specializes in protein drugs and vaccines.
He has successfully managed more than 50 formulation development and non-GMP DP manufacturing projects. In September 2022, he helped launch DEVELOPICK™, a platform that evaluates target molecules. Prior to joining Samsung Biologics in 2017, Heonchang served as a scientist at LG Chem, where he conducted R&D for purification and formulation development in multiple vaccine and protein drug projects.
He holds a master’s degree in medicine from Seoul National University and a bachelor’s degree in molecular biology from Catholic University.


Dr. Chuang received his PhD degree in Medicinal Chemistry from National Tsing Hua University. As a principal investigator in Development Center for Biotechnology (DCB), he led several drug discovery projects especially on oncology field. These topics include Top1 inhibitor, Nek2/Hec1 inhibitor, antibody-drug conjugates (ADC) and proteolysis targeting chimera (PROTAC). After more than 15 years, he left DCB and joined OBI Pharma as the director of Medicinal Chemistry and focusing on developing anti-Trop2 ADC. In 2022, Dr. Chuang co-founded HoneyBear Biosciences, and serve as the CEO.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Choose a plan that fits your role, company, and industry.
Early Bird Rate : SGD 1,495
(Valid until 2nd October 2025)
Registration Open Rate : SGD 1,695
(Valid until 4th December 2025)
Standard Rate : SGD 1,895
(Valid until 5th Feb 2026)
Final Call Rate : SGD 2,095
(Valid until 11th March 2026)
Applicable to company profiles (headquartered within the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 1,995
(Valid until 2nd October 2025)
Registration Open Rate : SGD 2,195
(Valid until 4th December 2025)
Standard Rate : SGD 2,395
(Valid until 5th Feb 2026)
Final Call Rate : SGD 2,595
(Valid until 11th March 2026)
Applicable to company profiles (headquartered outside of the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 4,295
(Valid until 2nd October 2025)
Registration Open Rate : SGD 4,495
(Valid until 4th December 2025)
Standard Rate : SGD 4,695
(Valid until 5th Feb 2026)
Final Call Rate : SGD 4,895
(Valid until 11th March 2026)
Applicable to company profiles:
Job Profiles: Business Development, Marketing, and Sales
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
Visit the awards page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.